Preconditioning via Angiotensin Type 2 Receptor Activation Improves Therapeutic Efficacy of Bone Marrow Mononuclear Cells for Cardiac Repair

• Yinchuan Xu ,

  Contributed equally to this work with: Yinchuan Xu, Xinyang Hu

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Xinyang Hu ,

  Contributed equally to this work with: Yinchuan Xu, Xinyang Hu

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Lihan Wang,

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Zhi Jiang,

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Xianbao Liu,

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Hong Yu,

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Zhaocai Zhang,

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Huiqiang Chen,

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Han Chen,

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯
• Gustav Steinhoff,

  Affiliation Reference and Translation Center for Cardiac Stem Cell Therapy, University of Rostock, Rostock, Germany

  ⨯
• Jun Li ,

  * E-mail: jian_an_wang@yahoo.com (JW); jun.li@sjtu.edu.cn (JL)

  Affiliation Clinical Stem Cell Research Center and Department of Cardiovascular Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  ⨯
• Jian’an Wang

  * E-mail: jian_an_wang@yahoo.com (JW); jun.li@sjtu.edu.cn (JL)

  Affiliations Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Cardiovascular key lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  ⨯